Does zopiclone increase alcohol tolerance in adults with insomnia or sleep disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Zopiclone Does Not Increase Alcohol Tolerance

Zopiclone does not increase alcohol tolerance; rather, it produces dangerous additive sedative effects when combined with alcohol, and patients must be explicitly warned to avoid this combination. 1

Critical Safety Warning

The combination of zopiclone with alcohol creates additive CNS depression that significantly impairs psychomotor performance and increases risk of serious adverse events. 1 This is a pharmacodynamic interaction where both substances enhance each other's sedative effects without altering the body's tolerance to either substance. 2

Mechanism of Interaction

  • Zopiclone acts as a GABA-A receptor agonist, producing sedation through enhancement of GABAergic neurotransmission 3
  • Alcohol also enhances GABA activity and depresses CNS function through multiple mechanisms 2
  • When combined, these agents produce additive sedative effects without pharmacokinetic interaction - meaning the blood levels of each drug remain unchanged, but their combined effects on the brain are amplified 2
  • Clinical trials specifically demonstrate that adding ethanol to zopiclone treatment results in additive sedative effects without altering the pharmacokinetic parameters of the drug 2

FDA and Guideline Warnings

All benzodiazepine receptor agonists, including zopiclone, carry explicit warnings about avoiding concomitant alcohol use. 1

The American Academy of Sleep Medicine guidelines specifically state:

  • Additive effect on psychomotor performance occurs with concomitant CNS depressants and/or alcohol use 1
  • The FDA has recommended warnings regarding adverse effects associated with benzodiazepine receptor agonist hypnotics, emphasizing the importance of avoiding the combination of these hypnotics with alcohol 1
  • Patients should be cautioned about using only prescribed doses and avoiding combination with alcohol, other sedatives, and sleep restriction 1

Clinical Implications

There is no evidence that zopiclone increases tolerance to alcohol or vice versa. The concern is entirely about the acute combined effects:

  • Enhanced sedation and drowsiness 2
  • Increased risk of complex sleep-related behaviors (sleep-driving, sleep-eating) 1
  • Greater cognitive and psychomotor impairment 1
  • Increased risk of respiratory depression, particularly in patients with compromised respiratory function 1
  • Higher risk of falls, accidents, and injuries 1

Special Populations at Higher Risk

  • Elderly patients are at increased risk for adverse effects from the combination and should receive lower doses of zopiclone (and avoid alcohol entirely) 1
  • Patients with compromised respiratory function (asthma, COPD, sleep apnea) face particular danger from combined CNS depression 1
  • Those with hepatic impairment may have prolonged effects of zopiclone and should use reduced doses while strictly avoiding alcohol 1

Common Clinical Pitfall

The most important pitfall is patients self-medicating insomnia with alcohol while taking prescribed zopiclone. 1 Clinicians must:

  • Explicitly counsel patients that alcohol will not improve sleep quality and creates dangerous interactions with zopiclone 1
  • Screen for alcohol use disorders before prescribing zopiclone, as patients with substance use history may be better candidates for non-scheduled alternatives like ramelteon 1
  • Emphasize that the combination does not build tolerance but rather compounds risk with each use 2

Patients who use alcohol to treat insomnia should not be prescribed zopiclone until alcohol use is addressed. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Eszopiclone: its use in the treatment of insomnia.

Neuropsychiatric disease and treatment, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.